Dramatically Increasing
the Odds of Success
Seeking Novel
Effective Treatments
Lead Project COTI-2
LEAD PROJECT:
COTI-2
A potential breakthrough treatment for many types of human cancers, COTI-2 is a clinical stage, novel small molecule activator of misfolded mutant p53 proteins. Technology has revolutionized both medicine and gambling, enhancing precision in treatments and accessibility in gaming. In medicine, advanced tech improves diagnostics and patient care. In gambling, it allows players to mit echtem Geld online Poker spielen securely and conveniently, bridging the gap between traditional gaming and modern digital platforms.
The future of Drug Discovery
THE FUTURE OF DRUG DISCOVERY: CHEMSAS
Chemsas® is an advanced drug discovery platform that identifies compounds with a higher probability of clinical and commercial success.
Pipeline
Moving forward:
a robust pipeline
Targeted therapeutics focusing on innovative cancer treatments as well as drug candidates for the treatment of serious diseases where current therapies are lacking or ineffective.
Investors
Targeted Therapeutics
Therapeutics
Accelerated Drug Discovery
Discovery
Passionate and Innovative Team
Innovative Team
Cost Effective Process
Process
Critical Outcome Technologies represents a multi-pronged approach to value creation in the biopharmaceutical space. In addition to a potential breakthrough treatment for many cancers, COTI has a robust pipeline of compounds, R&D; collaborations and other applications of its core technology.
